![Bethany Sensenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bethany Sensenig
Directeur/Membre du Conseil chez
SUPERNUS PHARMACEUTICALS
Fortune : 49 401 $ au 30/09/2026
Profil
Ms. Bethany L.
Sensenig is an Independent Director at Alpha Cognition, Inc., an Independent Director at Supernus Pharmaceuticals, Inc., a Chief Executive & Financial Officer at Naia Rare Diseases LLC and a Chief Financial Officer at CenExel Clinical Research, Inc. She is on the Board of Directors at Supernus, Inc., Alpha Cognition, Inc. and Supernus Pharmaceuticals, Inc. Ms. Sensenig was previously employed as an Independent Director by KalVista Pharmaceuticals, Inc., a Chief Financial Officer & Head-Operations by Radius Health, Inc., a Chief Executive & Financial Officer by 9 Meters Biopharma, Inc., a Chief Financial Officer & Head-US Operations by Minovia Therapeutics Ltd., and a Vice President-Finance & Commercial Operations by Biogen, Inc. She received her undergraduate degree from Montreat College and an MBA from Western Carolina University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COGNITION INC 0,03 % | 16/04/2026 | 5 489 ( 0,03 % ) | 49 401 $ | 30/09/2026 |
| 04/09/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Postes actifs de Bethany Sensenig
| Sociétés | Poste | Début |
|---|---|---|
| SUPERNUS PHARMACEUTICALS | Directeur/Membre du Conseil | 21/08/2023 |
| ALPHA COGNITION INC. | Directeur/Membre du Conseil | 15/04/2026 |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Directeur Général | - |
CenExel Clinical Research, Inc.
 CenExel Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research, medical and scientific support services for clinical trials | Directeur Financier/CFO | - |
Anciens postes connus de Bethany Sensenig
| Sociétés | Poste | Fin |
|---|---|---|
| KALVISTA PHARMA | Directeur/Membre du Conseil | 11/06/2026 |
| RADIUS HEALTH, INC. | Directeur Financier/CFO | 01/04/2026 |
| 9 METERS BIOPHARMA, INC. | Directeur Général | 17/07/2023 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. BiotechnologyHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Directeur Financier/CFO | 01/01/2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2019 |
Formation de Bethany Sensenig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Montreat College
 Montreat College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
 Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
CenExel Clinical Research, Inc.
CenExel Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research, medical and scientific support services for clinical trials | Commercial Services |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. BiotechnologyHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
